X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (533) 533
Patent (283) 283
Publication (43) 43
Conference Proceeding (22) 22
Book Chapter (20) 20
Book / eBook (16) 16
Magazine Article (8) 8
Dissertation (7) 7
Web Resource (5) 5
Book Review (4) 4
Streaming Audio (2) 2
Music Recording (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (147) 147
humans (134) 134
metallurgy (128) 128
male (105) 105
human necessities (100) 100
performing operations (99) 99
transporting (99) 99
general tagging of cross-sectional technologies spanning over several sections of the ipc (90) 90
general tagging of new technological developments (90) 90
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (90) 90
chemical or physical processes, e.g. catalysis or colloidchemistry (86) 86
physical or chemical processes or apparatus in general (86) 86
their relevant apparatus (86) 86
index medicus (85) 85
technologies or applications for mitigation or adaptation againstclimate change (78) 78
female (75) 75
analysis (66) 66
separation (64) 64
capture, storage, sequestration or disposal of greenhousegases [ghg] (62) 62
hygiene (60) 60
medical or veterinary science (60) 60
adult (59) 59
apparatus therefor (59) 59
preparations for medical, dental, or toilet purposes (59) 59
middle aged (56) 56
climate change mitigation technologies in the production orprocessing of goods (55) 55
organic chemistry (55) 55
chemical aspects of bandages, dressings, absorbent pads, orsurgical articles (53) 53
disinfection, sterilisation, or deodorisation of air (53) 53
materials for bandages, dressings, absorbent pads, or surgicalarticles (53) 53
methods or apparatus for sterilising materials or objects ingeneral (53) 53
inorganic chemistry (46) 46
animals (45) 45
compounds thereof (45) 45
non-metallic elements (45) 45
engineering, chemical (42) 42
acyclic or carbocyclic compounds (41) 41
electrochemistry (41) 41
bandages, dressings or absorbent pads (40) 40
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (40) 40
filters implantable into blood vessels (40) 40
first-aid kits (40) 40
fomentation (40) 40
orthopaedic, nursing or contraceptive devices (40) 40
prostheses (40) 40
treatment or protection of eyes or ears (40) 40
general methods of organic chemistry (38) 38
risk factors (38) 38
foods or foodstuffs (36) 36
their treatment, not covered by other classes (36) 36
chemistry, physical (34) 34
aged (33) 33
catalysts (33) 33
electricity (32) 32
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
kinetics (25) 25
electrodes (23) 23
electrolytes (23) 23
oncology (23) 23
research (23) 23
batteries (22) 22
reactors (22) 22
technologies for adaptation to climate change (22) 22
article (21) 21
electrolytic or electrophoretic processes (21) 21
electrolytic or electrophoretic processes for the productionof compounds or non-metals (21) 21
oxidation (21) 21
catalysis (20) 20
infection (20) 20
basic electric elements (19) 19
coffee (19) 19
manufacture, preparation, or infusion thereof (19) 19
tea (19) 19
their substitutes (19) 19
trapping (19) 19
agriculture (18) 18
animal husbandry (18) 18
biocides, e.g. as disinfectants, as pesticides, as herbicides (18) 18
electrolysis (18) 18
fishing (18) 18
forestry (18) 18
health aspects (18) 18
hunting (18) 18
mechanical engineering (18) 18
pest repellants or attractants (18) 18
plant growth regulators (18) 18
preservation of bodies of humans or animals or plants or partsthereof (18) 18
surgery (18) 18
virology (18) 18
adolescent (17) 17
blasting (17) 17
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (17) 17
heating (17) 17
lighting (17) 17
preservation of foods or foodstuffs, in general (17) 17
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (17) 17
production processes (17) 17
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (17) 17
weapons (17) 17
energy & fuels (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (5) 5
Online Resources - Online (5) 5
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Music - Circulation Desk (1) 1
University Archives - Archives (1) 1
University Archives - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (794) 794
German (106) 106
French (89) 89
Norwegian (13) 13
Polish (11) 11
Spanish (9) 9
Chinese (7) 7
Finnish (7) 7
Czech (6) 6
Portuguese (6) 6
Danish (5) 5
Swedish (5) 5
Hungarian (4) 4
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2017, 2nd ed. 2017., Environmental Science and Engineering, ISBN 9783319294933
This book starts by discussing the global flows of energy and materials and changes caused by human activities. It then examines the limitations of... 
Biotechnology | Environmental chemistry | Environment | Environmental engineering
Web Resource
2017, 2nd ed. 2017., Environmental Science and Engineering, ISBN 9783319294933
This book starts by discussing the global flows of energy and materials and changes caused by human activities. It then examines the limitations of... 
Biotechnology | Environmental chemistry | Environment | Environmental engineering
Web Resource
Nature Medicine, ISSN 1078-8956, 05/2011, Volume 17, Issue 5, pp. 589 - 595
Hepatitis C virus (HCV) is a major cause of liver disease, but therapeutic options are limited and there are no prevention strategies. Viral entry is the first... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | B TYPE-I | NEUTRALIZING ANTIBODIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | FACTOR RECEPTOR | CELL BIOLOGY | EPIDERMAL-GROWTH-FACTOR | CELL TRANSMISSION | HUMAN LIVER | INFECTION | ERLOTINIB | Erlotinib Hydrochloride | RNA, Small Interfering - genetics | Receptor, Epidermal Growth Factor - genetics | Hepatitis C - therapy | Humans | Virus Internalization - drug effects | RNA Interference | Membrane Proteins - physiology | Base Sequence | Hepacivirus - physiology | Hepatitis C - prevention & control | Receptor, Epidermal Growth Factor - physiology | Hepacivirus - drug effects | Cell Line | Antiviral Agents - pharmacology | Receptor, EphA2 - physiology | Tetraspanin 28 | Claudin-1 | Animals | Hepatitis C - virology | Receptor, EphA2 - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Antigens, CD - physiology | Hepatitis C - physiopathology | Ligands | Mice | Protein Kinase Inhibitors - pharmacology | Receptor, EphA2 - antagonists & inhibitors | Quinazolines - pharmacology | Host-Pathogen Interactions - physiology | Ephrin A | Antiviral agents | Care and treatment | Patient outcomes | Physiological aspects | Research | Hepatitis C | Hepatitis | Viruses | Drug therapy | Antiviral drugs | Receptor, EphA2 | Hépatology and Gastroenterology | Antigens, CD81 | Antiviral Agents | Quinazolines | Virus Internalization | Membrane Proteins | Host-Pathogen Interactions | Life Sciences | Human health and pathology | Protein Kinase Inhibitors | RNA, Small Interfering | Hepacivirus | Antigens, CD | Receptor, Epidermal Growth Factor | Liver | HCV escape variants | Cell-cell transmission | genetics | pharmacology | Antiviral | therapy | physiology | drug effects | prevention & control | antagonists & inhibitors | physiopathology | Phosphotyrosine kinase | virology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Journal Article